Plaquenil is the brand name of hydroxychloroquinone in the sulfate salt and is manufactured by Concordia Pharmaceuticals.
Here is the most current approved label.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/009768Orig1s051lbl.pdf
This is a very old drug that recently got approval “licensure” for...
1. Lupus Erythematosus -— PLAQUENIL is indicated for the treatment of chronic discoid lupus erythematosus and systemic lupus erythematosus in adults.
2. Rheumatoid Arthritis PLAQUENIL is indicated for the treatment of acute and chronic rheumatoid arthritis in adults.
The labelling does not include numbers of patients evaluated in the pharmacokinetics, safety, and efficacy evaluation for the submission, that I can find. But these data reside with the applicant and/or those doing the marketing for these indications (Mylan and Sanofi, maybe more).
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009768
mark
It sure seems that this is
going to turn out to be
a cure for the common cold.
How good is that?
For his next act President Trump will:
-Invent the 100mpg carburetor
-1M Mile tires
-A better mouse trap
-???
7
That’s it, thank you. Hope we begin to hear some positive results soon.